Endocrine disrupting chemicals are causing serious harm to health and increasing the disease burden worldwide and pose a global health risk by disrupting the endocrine system through various biological pathways. The combination of MIPs and QDs offers high sensitivity fluorescence analysis and holds promise for detection at very low concentrations. In recent years, quantum dots have found significant application in biomedical applications such as biosensors and clinical diagnosis due to their traceable optical properties. QDs have unique optical advantages such as high luminescence intensity, high molar extinction coefficient and customizable emission properties depending on their size. With the help of MIPs, QDs specifically recognize target analytes, interact with the fluorescent signal source and thus changes in the fluorescence intensity of the target analyte can be monitored. The presence of endocrine disrupting drugs in water, biological fluids, animal feed and meat samples is known as a result of studies. Considering the difficulty and durability of biodegradation of these drugs, their detection by QD/MIPs is of great importance. This review summarizes recent work on the development of fluorescent QD/MIP sensors for the detection of endocrine disrupting drugs.
Primary Language | English |
---|---|
Subjects | Pharmaceutical Analytical Chemistry |
Journal Section | Review Articles |
Authors | |
Publication Date | June 1, 2025 |
Submission Date | February 13, 2025 |
Acceptance Date | May 13, 2025 |
Published in Issue | Year 2025 Volume: 45 Issue: 2 |